Trending Stock News

Bellerophon Therapeutics Licenses INOpulse® Commercialization in Greater China to Baylor BioSciences
Bellerophon Therapeutics licenses INOpulse® commercialization to Baylor BioSciences in Greater China.

Acer Therapeutics Launches Two Investigator-Led Trials for ACER-801 (Osanetant) in Prostate Adenocarcinoma Patients
Acer Therapeutics initiates two investigator-led trials for ACER-801 (Osanetant) in treating Prostate Adenocarcinoma patients.

ePlus Introduces Storage-as-a-Service Backed by Pure Storage
ePlus now offers Storage-as-a-Service, powered by Pure Storage, providing flexible, scalable data solutions.

Plexus Announces Date for Release of Fiscal First Quarter 2023 Earnings
“Plexus to release Fiscal Q1 2023 earnings on announced date. Stay updated for insights on financial performance.”

The Value of a $1000 Investment in Catalyst Pharmaceutical 10 Years Later
Explore the growth of a $1000 investment in Catalyst Pharmaceutical over a decade. Uncover its value today.

ReWalk Technology Highlighted at Hanukkah Event Hosted by Israeli Embassy in Belgium and Luxembourg
“ReWalk Technology showcased at Hanukkah event by Israeli Embassy in Belgium and Luxembourg.”

Acasti Schedules Conference Call for January 10, 2023 to Review Successful Phase 1 PK Studies Results for GTX-101 and GTX-102
Join Acasti’s conference call on Jan 10, 2023, reviewing successful Phase 1 PK studies for GTX-101 & GTX-102.

CNS Pharmaceuticals to Feature in the 2023 Virtual Investor Companies to Watch Event
“CNS Pharmaceuticals to showcase at 2023 Virtual Investor Companies to Watch Event, highlighting their innovative solutions.”

2022 Accomplishments and 2023 Business Goals Announced by Cyclacel Pharmaceuticals
“Cyclacel Pharmaceuticals reveals 2022 achievements and sets ambitious business goals for 2023.”

Moderna (MRNA) Expands mRNA Portfolio Through OriCiro Acquisition
Moderna acquires OriCiro, expanding its mRNA portfolio to enhance genetic medicine development.

Is Keeping Willis Towers (WTW) in Your Portfolio a Good Idea?
Explore the pros and cons of keeping Willis Towers (WTW) in your portfolio. Analyze its performance, risks, and potential returns.

Two Promising Electronics Stocks to Monitor Amidst Industry Challenges
Explore two promising electronics stocks to watch, offering potential growth despite industry challenges.

Ambarella Introduces New CV3-AD685 to its CV3 Family of AI Automotive Domain Controllers
Ambarella unveils CV3-AD685, a new addition to its CV3 Family of AI Automotive Domain Controllers.

INVESTOR ALERT: Halper Sadeh LLC Probes LMST, BNFT, RBA for Potential Shareholder Violations
Halper Sadeh LLC investigates LMST, BNFT, RBA for possible shareholder violations. Stay alert, investors.

Biotech Stock Update: GERN Skyrockets Based on Study Data, PHAT and VERA Provide Latest News & More
Get the latest biotech stock updates: GERN soars on study data, with PHAT and VERA sharing recent news & more.
Nebius Group’s Recent Pullback: A Speculative Buy with Billionaire Backing
After a sharp decline from its recent highs, Nebius Group (OTC:NBIS) has caught the attention of savvy investors looking for
Stay Connected
Join our investor community to receive updates on Prairie’s continued growth story, earnings announcements, and strategic developments.
Receive quarterly updates, earnings alerts, and strategic announcements. Unsubscribe anytime.